With a 3-day agenda to explore, featuring 20+ expert speakers, 2 deep-dive workshops covering the latest in JAK inhibitors and clinical stratification, recruitment and endpoint strategies, thought-provoking panels on the future of inflammatory-drug development and unmissable interactive sessions to plan your market access strategy, download your copy to:
Learn who’s leading research in the shared and unique characteristics of AD, PN & CSU
Discover how clinical programs are revealing novel disease targets
Uncover technologies making biomarker-driven drug development a reality
Find out which candidates are progressing to the clinic and tactics bridging the translational gap
Get updates on clinical pipelines making headway towards improving long-term patient QoL
From topical to systemic and small molecule to biologic, get your copy to discover how Sanofi, Nektar Therapeutics, Affibody, Moonlake Therapeutics & more are shaping today’s dermatology drug development landscape and integrate learnings to expedite your route to market!
Who Will You Hear From?
“Good presentations and interesting new technologies from EU Biotech”
Kim Kjøller, Chief Executive Officer, Union Therapeutics